Soros Fund Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.4M Sell
22,199
-135
-0.6% -$137K 0.22% 104
2025
Q4
$24M Buy
+22,334
New +$21.4M 0.28% 93
2025
Q1
Sell
-33,639
Closed -$26M 243
2024
Q4
$26M Buy
+33,639
New +$27.9M 0.39% 70
2024
Q1
Sell
-33,000
Closed -$19.2M 233
2023
Q4
$19.2M Buy
+33,000
New +$19.3M 0.25% 95
2017
Q2
Sell
-3,900
Closed -$328K 269
2017
Q1
$328K Buy
+3,900
New +$312K 0.01% 190
2014
Q3
Sell
-50,441
Closed -$3.14M 311
2014
Q2
$3.14M Buy
+50,441
New +$3.01M 0.02% 228

Other funds holding LLY

Soros Fund Management's LLY Position: Q1 2026 in Review

Soros Fund Management reduced its Eli Lilly (LLY) stake by 0.6% in Q1 2026, selling an estimated $137K and leaving 22,199 shares worth $20.4M. The position accounts for 0.22% of the portfolio, ranked #104.

Soros Fund Management first reported a position in LLY in Q2 2014 and has held it in 6 quarters since. The position peaked at $26M in Q4 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Soros Fund Management held 22,199 shares of Eli Lilly worth $20.4M as of Q1 2026.
  • Soros Fund Management sold 135 Eli Lilly shares in Q1 2026, an estimated $137K.
  • Eli Lilly made up 0.22% of Soros Fund Management's portfolio in Q1 2026, its #104 holding.
  • Soros Fund Management first reported a position in Eli Lilly in Q2 2014 and has held it in 6 quarters since.
  • Soros Fund Management's Eli Lilly position peaked at $26M in Q4 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Soros Fund Management's 13F filing for Q1 2026, filed 15 May 2026.